Active Filter(s):
Details:
ALASTIN’s synergistic portfolio in skincare will increase Galderma’s ability to serve the needs by the patented TriHex Technology®, a blend of peptides (Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1) and active botanicals to support the appearance of rejuvenated skin.
Lead Product(s): Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract
Therapeutic Area: Dermatology Product Name: Alastin Skincare
Highest Development Status: Approved Product Type: Peptide
Partner/Sponsor/Collaborator: Galderma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition January 05, 2022
Details:
ALASTIN’s product offerings are backed by the patented TriHex Technology®, a proprietary blend of peptides and active botanicals to support the appearance of rejuvenated skin, which will now be apart of Galderma.
Lead Product(s): Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract
Therapeutic Area: Dermatology Product Name: Alastin Skincare
Highest Development Status: Approved Product Type: Peptide
Partner/Sponsor/Collaborator: Galderma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition November 29, 2021